« Back to Record
Citation APA

Hoskins, P., Vergote, I., Cervantes, A., Tu, D., Stuart, G., Zola, P., Poveda, A., Provencher, D., Katsaros, D., Ojeda, B., Ghatage, P., Grimshaw, R., Casado, M., Elit, L., Mendiola, C., Sugimoto, A., D'Hondt, V., Ozaita, A., Germa, J. R., Roy, M., Brotto, L., Chen, D., & Eisenhauer, E. (2010). Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel. Journal of the National Cancer Institute, 102(20), 1547-1556. doi:10.1093/jnci/djq362


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/118208

Hoskins, P., Vergote, I., Cervantes, A., Tu, D., Stuart, G., Zola, P., Poveda, A., Provencher, D., Katsaros, D., Ojeda, B., Ghatage, P., Grimshaw, R., Casado, M., Elit, L., Mendiola, C., Sugimoto, A., D'Hondt, V., Ozaita, A., Germa, J. R., Roy, M., Brotto, L., Chen, D., & Eisenhauer, E. (2010). Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel. Journal of the National Cancer Institute, 102(20), 1547-1556. doi:10.1093/jnci/djq362